Jean-Patrick Demonsang

Vorsitzender bei Demonsang Consulting SAS

71 Jahre

Finance

Health Technology

Consumer Services

Aktive Positionen von Jean-Patrick Demonsang

Unternehmen	Position	Beginn	Ende
Demonsang Consulting SAS	Vorsitzender	-	-

Unternehmen	Position	Beginn	Ende
OSE IMMUNOTHERAPEUTICS	Direktor/Vorstandsmitglied	10.04.2014	22.06.2023
OSE IMMUNOTHERAPEUTICS	Independent Dir/Board Member	10.04.2014	22.06.2023
Seventure Partners SA Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.	Vorstandsvorsitzender	21.06.2010	01.01.2013
	Vorsitzender	01.09.1999	01.01.2013
	Präsident	01.09.1999	01.01.2013
Natixis Venture Sélection SA Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages.	Direktor/Vorstandsmitglied	-	-
Genode Partners SAS	Vorstandsvorsitzender	-	-
Parexi SAS	Vorsitzender	-	-
G1j Ile De France	Vorsitzender	-	-
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France.	Direktor/Vorstandsmitglied	10.04.2014	-
	Independent Dir/Board Member	10.04.2014	-

École des Hautes Études Commerciales de Paris

Masters Business Admin

International

Frankreich

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Private Unternehmen	7
Seventure Partners SA Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.	Finance
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France.	Health Technology
Demonsang Consulting SAS
G1j Ile De France
Parexi SAS
Genode Partners SAS
Natixis Venture Sélection SA Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages.	Finance